Beamtree Holdings Ltd (ASX: BMT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Beamtree Holdings Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $63.58 million
P/E Ratio 384.62
Dividend Yield 0.00%
Shares Outstanding 288.98 million
Earnings per share -0.022
Dividend per share N/A
Year To Date Return -6.38%
Earnings Yield 0.26%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Beamtree Holdings Ltd (ASX: BMT)
    Latest News

    Two kids in superhero capes.
    Ask a Fund Manager

    2 small-cap ASX shares to handsomely reward patient investors

    Ask A Fund Manager: SG Hiscock's Rory Hunter reveals the 2 little-known stocks that will put smiles on investor faces…

    Read more »

    a man sits on a rocket propelled office chair and flies high above a city
    Technology Shares

    Beamtree (ASX: BMT) share price rockets 21% on acquisition news

    It's a big day on the ASX for Beamtree. Here's what's sent its shares skyrocketing.

    Read more »

    Frequently Asked Questions

    No, Beamtree does not pay dividends at this time.

    Beamtree Holdings Ltd listed on the ASX on 6 June 2019.

    BMT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Beamtree Holdings Ltd

    Beamtree Holdings Ltd (ASX: BMT) is a technology company involved in health data analytics. Its software incorporates artificial intelligence and machine learning to provide an integrated platform for information and knowledge management for health providers.

    Beamtree's platform offers end-to-end support from data collection and classification through quality and performance benchmarking to clinical decision support at point of care. 

    The company says its products help healthcare providers to meet critical challenges in four key areas: rising demand, financial decision-making, quality of clinical outcomes, and patient experience.

    Beamtree products are currently being used at more than one thousand sites in 20 countries across four continents.

    BMT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    21 Jun 2024 $0.22 $0.01 4.65% 84,605 $0.22 $0.23 $0.22
    20 Jun 2024 $0.22 $0.01 4.88% 42,110 $0.21 $0.22 $0.21
    19 Jun 2024 $0.21 $-0.01 -4.76% 142,312 $0.21 $0.21 $0.21
    18 Jun 2024 $0.21 $-0.01 -4.65% 221,825 $0.22 $0.22 $0.20
    17 Jun 2024 $0.22 $-0.01 -4.55% 78,215 $0.22 $0.22 $0.22
    14 Jun 2024 $0.22 $0.00 0.00% 373,985 $0.22 $0.22 $0.21
    13 Jun 2024 $0.22 $0.01 4.65% 37,500 $0.22 $0.22 $0.22
    12 Jun 2024 $0.22 $-0.01 -4.55% 28,363 $0.22 $0.22 $0.22
    11 Jun 2024 $0.22 $0.00 0.00% 45,435 $0.22 $0.22 $0.22
    07 Jun 2024 $0.22 $0.00 0.00% 181,004 $0.23 $0.23 $0.22
    06 Jun 2024 $0.22 $-0.01 -4.35% 56,226 $0.22 $0.22 $0.22
    05 Jun 2024 $0.23 $0.01 4.44% 15,000 $0.23 $0.23 $0.23
    03 Jun 2024 $0.23 $-0.01 -4.35% 46,677 $0.23 $0.23 $0.23
    31 May 2024 $0.23 $0.00 0.00% 139,844 $0.23 $0.23 $0.23
    30 May 2024 $0.23 $0.00 0.00% 112,276 $0.23 $0.24 $0.23
    29 May 2024 $0.24 $-0.01 -4.17% 87,055 $0.24 $0.24 $0.24
    28 May 2024 $0.24 $0.01 4.35% 556,582 $0.24 $0.24 $0.23
    27 May 2024 $0.23 $0.01 4.44% 1,464,823 $0.24 $0.25 $0.23

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    08 May 2024 Emma Gray Buy 60 $12
    On-market trade.
    07 May 2024 Emma Gray Buy 180,822 $37,068
    On-market trade.
    06 May 2024 Emma Gray Buy 669,178 $127,143
    On-market trade.
    02 May 2024 Emma Gray Buy 19,750,000 $4,147,500
    Off-market trade.
    09 Apr 2024 Emma Gray Issued 71,429 $15,000
    Employee Share Ownership Plan/Directors Salary Sacrifice.
    09 Apr 2024 Brad Lancken Issued 71,429 $15,000
    Employee Share Ownership Plan/Directors Salary Sacrifice.
    09 Apr 2024 Jim Birch Issued 71,429 $15,000
    Employee Share Ownership Plan/Directors Salary Sacrifice.
    09 Apr 2024 Michael (Mike) Hill Issued 71,429 $15,000
    Employee Share Ownership Plan/Directors Salary Sacrifice.
    27 Mar 2024 Michael (Mike) Hill Buy 142,000 $29,820
    On-market trade.
    22 Dec 2023 Jim Birch Issued 120,000 $30,000
    Issue of securities.
    22 Dec 2023 Brad Lancken Issued 200,000 $50,000
    Issue of securities.
    22 Dec 2023 Brad Lancken Issued 1,000,000 $230,000
    Conversion of securities.
    22 Dec 2023 Brad Lancken Exercise 1,000,000 $230,000
    Conversion of securities.
    22 Dec 2023 Emma Gray Issued 200,000 $50,000
    Issue of securities.
    31 Aug 2023 Michael (Mike) Hill Buy 45,000 $10,485
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Jim Birch Non-Executive Director Mar 2021
    Mr Birch has more than 30 years' experience in implementing technological change in the healthcare industry, having previously served as Chair of the Australian digital Health Agency, Deputy Chair of the Independent Hospital Pricing Authority, CEO of the SA Department of Health, and global healthcare leader for consulting firm EY. Jim is currently Chair of the Little Company of Mary Health Care (Calvary), the Australian Red Cross Blood Service (now known as Lifeblood), the SA Women's and Children's Health Network and Clevertar Pty Ltd.
    Mr Michael (Mike) Hastings Hill Non-Executive ChairmanNon-Executive Director Jun 2018
    Mr Hill has been involved in working with management teams and boards across a number of companies and industries for more than 20 years. He is the MD & CIO, Founder of the Bombora Special Investment Growth Fund. Prior to Bombora he was an Investment Partner with Ironbridge. Mike has served as Chairman of range of ASX-listed companies over the past nine years. His other directorship included Design Milk Co Limited (Non-Executive Chairman), Janison Education Group Limited (Non-Executive Chairman), Mad Paws Holdings Limited (Non-Executive Director) and Gratifii Limited (Non-Executive Director). He is Member of Risk Committee.
    Mr Brad Lancken Non-Executive Director Oct 2019
    Mr Lancken is an experienced private and public company executive with over 15 years' experience and is a Managing Partner of Liverpool Partners with former roles at Archer Capital and Seven Group Holdings Limited. Brad has global experience in the technology and SaaS sector including currently acting as a Director of Seisma Technology Services and former roles on the advisory board of China Media Capital Partners and as a Board Director of Onesource Group and iseekplant.com.au. He also has domestic health care experience having led investments in the aged care sector, currently a Director of residential aged care provider CraigCare and serves the community as a Director of the NSW Institute of Sport.
    Ms Emma Gray Non-Executive Director Nov 2022
    Ms Gray is an experienced global business executive with over 20 years of experience in operations, strategy and digital transformation specially in the retail, consumer and banking sectors. Emma was with ANZ Banking Group for the last 5 years, most recently as Group Executive, Data and Automation having
    previously been it's Chief Data Officer. Prior to joining ANZ, Emma was a Group
    Executive with Woolworths, where she focused on Loyalty, Data and Strategy.
    Prior to executive life, Emma was a partner with Bain & Company, where she
    specialised in the retail and consumer segments, working across Australia, the
    United States and the United Kingdom for 15 years.
    Professor Mark Britnell Non-Executive Director May 2024
    Prof Britnell has worked in more than 81 countries, advising governments and health systems on improving outcomes and value with expertise in supporting transformation through adoption of digital technologies, including AI and workforce automation. Prof Britnell is an active leader in all Beamtrees key growth markets including Australia and New Zealand, Saudi Arabia, Canada and the UK and was formerly global head of health for KMPG. He also chairs the Beamtree Global Impact Committee, a group of international experts who promote thought leadership on improving health outcomes in global healthcare Prof Britnell is a professor at the Global Business School for Health at University College London and at the Rotman School of Management, University of Toronto. He started his career on the NHS Graduate Management Training Scheme . He joined KPMG in 2009 as Global Head of Health and later became Global Head of Health, Government & Infrastructure, responsible for nearly one-quarter of KPMG global revenues. He was made Vice Chair of KPMG UK in 2020 .
    Mr Timothy Kelsey Chief Executive Officer Oct 2020
    -
    Ms Belinda Ann Cleminson Joint Company Secretary Apr 2021
    -
    Ms Maria Clemente Joint Company Secretary May 2024
    -
    Timothy Kelsey Chief Executive Officer
    -
    Belinda Ann Cleminson Joint Company Secretary
    -
    Maria Clemente Joint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    National Nominees Limited 19,700,000 7.40%
    Freestate Holdings Pty Ltd 17,896,624 6.72%
    Hsbc Custody Nominees (Australia) Limited 17,881,114 6.72%
    Mirrabooka Investments Limited 15,680,000 5.89%
    Celerity Nominees Pty Limited 11,484,505 4.32%
    Amcil Limited 10,045,097 3.77%
    Paul Richard O'Connor 9,330,330 3.51%
    Sandtree Pty Ltd 9,037,575 3.40%
    Shorebrook Pty Ltd 8,492,011 3.19%
    3Rd Wave Investors Pty Ltd 6,200,000 2.33%
    Netwealth Investments Limited 6,091,245 2.29%
    Citicorp Nominees Pty Limited 3,995,810 1.50%
    Ozren Tosic 3,273,150 1.23%
    K M Fitzpatrick & Associates Pty Ltd 3,230,000 1.21%
    Castlereagh Equity Pty Ltd 2,830,000 1.06%
    Mr Christopher Bell 2,499,000 0.94%
    Mrs Clare Mapledora 2,250,000 0.85%
    David Bambach 2,073,545 0.78%
    Mary Ethna Black 1,728,144 0.65%
    Mohamed Hassan Khadra 1,728,137 0.65%

    Profile

    since

    Note